FR2951377B1 - Association d'un lysat de probiotique et d'un derive c-glycoside - Google Patents

Association d'un lysat de probiotique et d'un derive c-glycoside

Info

Publication number
FR2951377B1
FR2951377B1 FR0957374A FR0957374A FR2951377B1 FR 2951377 B1 FR2951377 B1 FR 2951377B1 FR 0957374 A FR0957374 A FR 0957374A FR 0957374 A FR0957374 A FR 0957374A FR 2951377 B1 FR2951377 B1 FR 2951377B1
Authority
FR
France
Prior art keywords
association
glycoside derivative
probiotic lysate
probiotic
lysate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0957374A
Other languages
English (en)
Other versions
FR2951377A1 (fr
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0957374A priority Critical patent/FR2951377B1/fr
Priority to PCT/IB2010/054744 priority patent/WO2011048554A2/fr
Publication of FR2951377A1 publication Critical patent/FR2951377A1/fr
Application granted granted Critical
Publication of FR2951377B1 publication Critical patent/FR2951377B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0957374A 2009-10-21 2009-10-21 Association d'un lysat de probiotique et d'un derive c-glycoside Active FR2951377B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0957374A FR2951377B1 (fr) 2009-10-21 2009-10-21 Association d'un lysat de probiotique et d'un derive c-glycoside
PCT/IB2010/054744 WO2011048554A2 (fr) 2009-10-21 2010-10-20 Association d'un lysat de probiotique et d'un derive c-glycoside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0957374A FR2951377B1 (fr) 2009-10-21 2009-10-21 Association d'un lysat de probiotique et d'un derive c-glycoside

Publications (2)

Publication Number Publication Date
FR2951377A1 FR2951377A1 (fr) 2011-04-22
FR2951377B1 true FR2951377B1 (fr) 2012-06-22

Family

ID=42244536

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0957374A Active FR2951377B1 (fr) 2009-10-21 2009-10-21 Association d'un lysat de probiotique et d'un derive c-glycoside

Country Status (2)

Country Link
FR (1) FR2951377B1 (fr)
WO (1) WO2011048554A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343361B2 (en) 2012-01-16 2025-07-01 Labyrinth Holdings, Llc Compositions and methods for the treatment of hepatic diseases and disorders

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
US20140086849A1 (en) 2012-09-21 2014-03-27 Elizabeth McKenna Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
CN104105471B (zh) 2012-02-14 2018-03-13 宝洁公司 皮肤共生益生元剂和包含其的组合物的局部使用
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
EP3435765A1 (fr) 2016-03-31 2019-02-06 Gojo Industries, Inc. Composition désinfectante de stimulation de peptides antimicrobiens
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
FR3055799B1 (fr) 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
FR3097441B1 (fr) * 2019-06-24 2021-06-25 Oreal Composition cosmétique comprenant un lysat deBifidobacterium species, un extrait de levure du genreSaccharomyces, et un monosaccharide mannose et ses utilisations cosmétiques

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
US5658880A (en) 1993-06-16 1997-08-19 Glycomed Incorporated Sialic acid/fucose based medicaments
US5508387A (en) 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
US5614615A (en) 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
WO2002028402A1 (fr) * 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Utilisation de bacteries lactiques probiotiques afin d'equilibrer le systeme immunitaire de la peau
FR2818547B1 (fr) 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
CA2493690C (fr) 2002-06-13 2011-11-08 New York University C-glycolipide de synthese et utilisation de celui-ci pour le traitement du cancer, des maladies infectieuses et des maladies auto-immunes
FR2886297B1 (fr) * 2005-05-30 2007-11-23 Oreal Composes c-glycosides et leur utilisation pur depigmenter la peau
WO2007116012A1 (fr) * 2006-04-07 2007-10-18 L'oréal Utilisation d'un composé c-glycoside dérivé du l-fucose et du d-fucose en tant qu'agent pour activer et réguler l'immunité cutanée
FR2899588B1 (fr) * 2006-04-07 2009-02-27 Oreal Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
FR2920306B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation cosmetique d'un lysat de bifidobacterieum species.
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343361B2 (en) 2012-01-16 2025-07-01 Labyrinth Holdings, Llc Compositions and methods for the treatment of hepatic diseases and disorders

Also Published As

Publication number Publication date
WO2011048554A3 (fr) 2011-06-23
WO2011048554A2 (fr) 2011-04-28
FR2951377A1 (fr) 2011-04-22

Similar Documents

Publication Publication Date Title
BRPI1011813A2 (pt) "inalador"
FR2941508B1 (fr) Agencement d'entrainement
EP2411101A4 (fr) Suivi d'événements d'entraînement physique
EP2377028A4 (fr) Modification d'instructions
IL216166A0 (en) Uses of immunoconjugats targeting cd138
EP2511268A4 (fr) Dérivé d'oxazine
BR112012004444A2 (pt) "laringoscópio"
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BR112012015789A2 (pt) 'artigo do vestuário descartável'
EP2471786A4 (fr) Dérivé d'aminopyrazole
EP2467842A4 (fr) Simulateur d'endoscope
FR2950411B1 (fr) Agencement d'entrainement
BR112012015788A2 (pt) 'artigo do vestuário descartável'
BRPI1013762A2 (pt) "derivados isoxazol-piridazina"
PL2236710T3 (pl) Kajdanki jednorazowego użytku
EP2376915A4 (fr) Détection d'oligosaccharides
EP2409977A4 (fr) Dérivé d'amide
EP2515659A4 (fr) Combinaison d'herbicides
ZA201204347B (en) New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
IL192700A0 (en) Use of elderberry extract
IL248077A0 (en) Formulations, salts and polymers of transnorsertraline and their uses
BRPI1009059A2 (pt) "peça de vestuário"
ZA201108458B (en) Nitrile derivatives and their pharmaceutical use and compositions
PL2120590T3 (pl) Zastosowanie Lactobacillus casei do wzmocnienia ochrony wywoływanej przez szczepienie przeciw grypie
EP2463279A4 (fr) Dérivé d'amide

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16